Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Concentration of revenue (Details)

v3.22.2.2
Significant Accounting Policies - Concentration of revenue (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Concentration Risk [Line Items]            
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Predecessor Predecessor Successor Predecessor
Total Revenue by Year   $ 269,453,971 $ 144,586,444   $ 542,998,305 $ 295,884,386
Revenue | Customer Concentration            
Concentration Risk [Line Items]            
Total Revenue by Year   $ 269,453,971 $ 144,586,444   $ 542,998,305 $ 295,884,386
Percentage of total revenue   100.00% 100.00%   100.00% 100.00%
Health Plan A | Revenue | Customer Concentration            
Concentration Risk [Line Items]            
Total Revenue by Year   $ 48,047,307 $ 39,119,191   $ 93,285,372 $ 77,813,676
Percentage of total revenue   17.80% 27.10%   17.20% 26.30%
Health Plan B | Revenue | Customer Concentration            
Concentration Risk [Line Items]            
Total Revenue by Year   $ 45,818,789 $ 33,449,667   $ 93,838,172 $ 67,034,039
Percentage of total revenue   17.00% 23.20%   17.30% 22.70%
Health Plan C | Revenue | Customer Concentration            
Concentration Risk [Line Items]            
Total Revenue by Year   $ 54,392,897 $ 18,412,847   $ 109,714,073 $ 37,693,084
Percentage of total revenue   20.20% 12.70%   20.20% 12.70%
Health Plan D | Revenue | Customer Concentration            
Concentration Risk [Line Items]            
Total Revenue by Year   $ 36,013,196 $ 27,231,621   $ 72,876,157 $ 54,925,880
Percentage of total revenue   13.40% 18.80%   13.40% 18.60%
All Other | Revenue | Customer Concentration            
Concentration Risk [Line Items]            
Total Revenue by Year   $ 85,181,782 $ 26,373,118   $ 173,284,531 $ 58,417,707
Percentage of total revenue   31.60% 18.20%   31.90% 19.70%